Related Experiment Videos
[Cellular immune response to mycobacterial antigens]
D Ordway1, M F Moraes, L Oliveira
1Centro de Malária e Outras Doenças Tropicais/IHMT e Hospital Egas Moniz, Lisboa.
Acta Medica Portuguesa
|February 18, 1999
Summary
Anti-tuberculous therapy significantly boosted immune responses, including T-cell activity and gamma-interferon production, in a disseminated tuberculosis patient. These improvements suggest effective treatment and highlight the role of specific M. tuberculosis antigens in protective immunity.
Area of Science:
- Immunology
- Infectious Diseases
- Tuberculosis Research
Background:
- Investigated the immunological response in a young, HIV-negative male with disseminated tuberculosis involving vertebral lesions and abscesses.
- Assessed immune markers like blastogenic and cytotoxic responses, and gamma-interferon (IFN) secretion against Mycobacterium tuberculosis antigens.
- Analyzed mRNA expression of cytokines (gamma-IFN, IL-4, IL-10) to understand their role during infection.
Observation:
- Initial therapy showed a slight increase in lymphocyte proliferation and gamma-IFN production towards purified protein derivative (PPD) and short-term culture filtrate proteins (ST-CFP).
- A notable increase in Mycobacterium tuberculosis and PPD-specific cytolytic T lymphocyte response was observed after one month.
- Significant improvements in blastogenic, cytotoxic responses, and gamma-IFN production were seen after six months of treatment, with a CD4/CD8 ratio increase.
Findings:
- Short-term and M. tuberculosis culture filtrate proteins (ST-CFP and MT-CFP) induced enhanced lymphoproliferation and gamma-IFN production, indicating their role in protective immunity.
- The patient's immune response profile suggests that reduced peripheral blood responses may reflect high activity at local infection sites.
- Disseminated tuberculosis in this case might be linked to nutritional/social factors or inherent reduced resistance.
Implications:
- Demonstrates the effectiveness of anti-tuberculous therapy in restoring cellular and cytokine-mediated immune responses.
- Highlights specific M. tuberculosis antigens (ST-CFP, MT-CFP) as crucial targets for stimulating protective immunity.
- Suggests potential links between host factors (nutritional, social) and susceptibility to disseminated tuberculosis infection.